 | • レポートコード：MRC2-11QY04651 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は小細胞肺がん治療薬のグローバル市場について調査・分析したレポートです。種類別（生物製剤、小分子）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別小細胞肺がん治療薬の競争状況、市場シェア ・世界の小細胞肺がん治療薬市場：種類別市場規模 2015年-2020年（生物製剤、小分子） ・世界の小細胞肺がん治療薬市場：種類別市場規模予測 2021年-2026年（生物製剤、小分子） ・世界の小細胞肺がん治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の小細胞肺がん治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の小細胞肺がん治療薬市場分析：米国、カナダ ・ヨーロッパの小細胞肺がん治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの小細胞肺がん治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の小細胞肺がん治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの小細胞肺がん治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Bristol-Myers Squibb、GlaxoSmithKline、Menarini、Ziopharm Oncology、Merck、Novartis、AstraZeneca、Takeda Pharmaceutical、Teva Pharmaceutical、Eli Lilly、Mylan、Sun Pharmaceuticals Industries、Amgen、Ono Pharmaceutical、Shanghai Jinhe Bio-Technology ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell carcinoma. It can be further classified into two stages: limited-stage small cell lung cancer and extensive-stage small cell lung cancer. Small cell lung cancer is caused by smoking tobacco, or second hand smoking, or on exposure to asbestos, chromium, arsenic, nickel, soot, or radon. The common symptoms associated with lung cancer are chest pain, incurable cough, blood in sputum, fatigue, loss of appetite, unintentional weight loss, shortness of breath, and wheezing. Small cell lung cancer has a poor prognosis and gets diagnosed only at the late stage of disease progression, and hence, has a high mortality rate. There are no therapies available to cure small cell lung cancer in the market.
Market Analysis and Insights: Global Small Cell Lung Cancer Therapeutics Market
The global Small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Small Cell Lung Cancer Therapeutics Scope and Market Size
Small Cell Lung Cancer Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Small Cell Lung Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sanofi
Bristol-Myers Squibb
GlaxoSmithKline
Menarini
Ziopharm Oncology
Merck
Novartis
AstraZeneca
Takeda Pharmaceutical
Teva Pharmaceutical
Eli Lilly
Mylan
Sun Pharmaceuticals Industries
Amgen
Ono Pharmaceutical
Shanghai Jinhe Bio-Technology
Market segment by Type, the product can be split into
Biologics
Small molecules
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Small Cell Lung Cancer Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biologics
1.4.3 Small molecules
1.5 Market by Application
1.5.1 Global Small Cell Lung Cancer Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Small Cell Lung Cancer Therapeutics Market Perspective (2015-2026)
2.2 Global Small Cell Lung Cancer Therapeutics Growth Trends by Regions
2.2.1 Small Cell Lung Cancer Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Small Cell Lung Cancer Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Small Cell Lung Cancer Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Small Cell Lung Cancer Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Small Cell Lung Cancer Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Small Cell Lung Cancer Therapeutics Players by Market Size
3.1.1 Global Top Small Cell Lung Cancer Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Small Cell Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Small Cell Lung Cancer Therapeutics Market Concentration Ratio
3.2.1 Global Small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Small Cell Lung Cancer Therapeutics Revenue in 2019
3.3 Small Cell Lung Cancer Therapeutics Key Players Head office and Area Served
3.4 Key Players Small Cell Lung Cancer Therapeutics Product Solution and Service
3.5 Date of Enter into Small Cell Lung Cancer Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Small Cell Lung Cancer Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)
5.2 Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Small Cell Lung Cancer Therapeutics Market Size (2015-2020)
6.2 Small Cell Lung Cancer Therapeutics Key Players in North America (2019-2020)
6.3 North America Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020)
6.4 North America Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Small Cell Lung Cancer Therapeutics Market Size (2015-2020)
7.2 Small Cell Lung Cancer Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020)
7.4 Europe Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Small Cell Lung Cancer Therapeutics Market Size (2015-2020)
8.2 Small Cell Lung Cancer Therapeutics Key Players in China (2019-2020)
8.3 China Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020)
8.4 China Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Small Cell Lung Cancer Therapeutics Market Size (2015-2020)
9.2 Small Cell Lung Cancer Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020)
9.4 Japan Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Small Cell Lung Cancer Therapeutics Market Size (2015-2020)
10.2 Small Cell Lung Cancer Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Small Cell Lung Cancer Therapeutics Market Size (2015-2020)
11.2 Small Cell Lung Cancer Therapeutics Key Players in India (2019-2020)
11.3 India Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020)
11.4 India Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Small Cell Lung Cancer Therapeutics Market Size (2015-2020)
12.2 Small Cell Lung Cancer Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Small Cell Lung Cancer Therapeutics Introduction
13.1.4 Sanofi Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Details
13.2.2 Bristol-Myers Squibb Business Overview
13.2.3 Bristol-Myers Squibb Small Cell Lung Cancer Therapeutics Introduction
13.2.4 Bristol-Myers Squibb Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020)
13.2.5 Bristol-Myers Squibb Recent Development
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Details
13.3.2 GlaxoSmithKline Business Overview
13.3.3 GlaxoSmithKline Small Cell Lung Cancer Therapeutics Introduction
13.3.4 GlaxoSmithKline Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020)
13.3.5 GlaxoSmithKline Recent Development
13.4 Menarini
13.4.1 Menarini Company Details
13.4.2 Menarini Business Overview
13.4.3 Menarini Small Cell Lung Cancer Therapeutics Introduction
13.4.4 Menarini Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020)
13.4.5 Menarini Recent Development
13.5 Ziopharm Oncology
13.5.1 Ziopharm Oncology Company Details
13.5.2 Ziopharm Oncology Business Overview
13.5.3 Ziopharm Oncology Small Cell Lung Cancer Therapeutics Introduction
13.5.4 Ziopharm Oncology Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020)
13.5.5 Ziopharm Oncology Recent Development
13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview
13.6.3 Merck Small Cell Lung Cancer Therapeutics Introduction
13.6.4 Merck Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020)
13.6.5 Merck Recent Development
13.7 Novartis
13.7.1 Novartis Company Details
13.7.2 Novartis Business Overview
13.7.3 Novartis Small Cell Lung Cancer Therapeutics Introduction
13.7.4 Novartis Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020)
13.7.5 Novartis Recent Development
13.8 AstraZeneca
13.8.1 AstraZeneca Company Details
13.8.2 AstraZeneca Business Overview
13.8.3 AstraZeneca Small Cell Lung Cancer Therapeutics Introduction
13.8.4 AstraZeneca Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020)
13.8.5 AstraZeneca Recent Development
13.9 Takeda Pharmaceutical
13.9.1 Takeda Pharmaceutical Company Details
13.9.2 Takeda Pharmaceutical Business Overview
13.9.3 Takeda Pharmaceutical Small Cell Lung Cancer Therapeutics Introduction
13.9.4 Takeda Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020)
13.9.5 Takeda Pharmaceutical Recent Development
13.10 Teva Pharmaceutical
13.10.1 Teva Pharmaceutical Company Details
13.10.2 Teva Pharmaceutical Business Overview
13.10.3 Teva Pharmaceutical Small Cell Lung Cancer Therapeutics Introduction
13.10.4 Teva Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020)
13.10.5 Teva Pharmaceutical Recent Development
13.11 Eli Lilly
10.11.1 Eli Lilly Company Details
10.11.2 Eli Lilly Business Overview
10.11.3 Eli Lilly Small Cell Lung Cancer Therapeutics Introduction
10.11.4 Eli Lilly Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020)
10.11.5 Eli Lilly Recent Development
13.12 Mylan
10.12.1 Mylan Company Details
10.12.2 Mylan Business Overview
10.12.3 Mylan Small Cell Lung Cancer Therapeutics Introduction
10.12.4 Mylan Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020)
10.12.5 Mylan Recent Development
13.13 Sun Pharmaceuticals Industries
10.13.1 Sun Pharmaceuticals Industries Company Details
10.13.2 Sun Pharmaceuticals Industries Business Overview
10.13.3 Sun Pharmaceuticals Industries Small Cell Lung Cancer Therapeutics Introduction
10.13.4 Sun Pharmaceuticals Industries Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020)
10.13.5 Sun Pharmaceuticals Industries Recent Development
13.14 Amgen
10.14.1 Amgen Company Details
10.14.2 Amgen Business Overview
10.14.3 Amgen Small Cell Lung Cancer Therapeutics Introduction
10.14.4 Amgen Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020)
10.14.5 Amgen Recent Development
13.15 Ono Pharmaceutical
10.15.1 Ono Pharmaceutical Company Details
10.15.2 Ono Pharmaceutical Business Overview
10.15.3 Ono Pharmaceutical Small Cell Lung Cancer Therapeutics Introduction
10.15.4 Ono Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020)
10.15.5 Ono Pharmaceutical Recent Development
13.16 Shanghai Jinhe Bio-Technology
10.16.1 Shanghai Jinhe Bio-Technology Company Details
10.16.2 Shanghai Jinhe Bio-Technology Business Overview
10.16.3 Shanghai Jinhe Bio-Technology Small Cell Lung Cancer Therapeutics Introduction
10.16.4 Shanghai Jinhe Bio-Technology Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020)
10.16.5 Shanghai Jinhe Bio-Technology Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Small Cell Lung Cancer Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Small Cell Lung Cancer Therapeutics Revenue
Table 3. Ranking of Global Top Small Cell Lung Cancer Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biologics
Table 6. Key Players of Small molecules
Table 7. Global Small Cell Lung Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Small Cell Lung Cancer Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Small Cell Lung Cancer Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Small Cell Lung Cancer Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Small Cell Lung Cancer Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Small Cell Lung Cancer Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Small Cell Lung Cancer Therapeutics Players
Table 18. Global Small Cell Lung Cancer Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Small Cell Lung Cancer Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Cell Lung Cancer Therapeutics as of 2019)
Table 21. Global Small Cell Lung Cancer Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Small Cell Lung Cancer Therapeutics Product Solution and Service
Table 24. Date of Enter into Small Cell Lung Cancer Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Small Cell Lung Cancer Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Small Cell Lung Cancer Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Small Cell Lung Cancer Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Small Cell Lung Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Small Cell Lung Cancer Therapeutics Market Share (2019-2020)
Table 34. North America Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Small Cell Lung Cancer Therapeutics Market Share by Type (2015-2020)
Table 36. North America Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Small Cell Lung Cancer Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Small Cell Lung Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Small Cell Lung Cancer Therapeutics Market Share (2019-2020)
Table 40. Europe Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Small Cell Lung Cancer Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Small Cell Lung Cancer Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Small Cell Lung Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Small Cell Lung Cancer Therapeutics Market Share (2019-2020)
Table 46. China Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Small Cell Lung Cancer Therapeutics Market Share by Type (2015-2020)
Table 48. China Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Small Cell Lung Cancer Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Small Cell Lung Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Small Cell Lung Cancer Therapeutics Market Share (2019-2020)
Table 52. Japan Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Small Cell Lung Cancer Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Small Cell Lung Cancer Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Small Cell Lung Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Small Cell Lung Cancer Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Small Cell Lung Cancer Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Small Cell Lung Cancer Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Small Cell Lung Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Small Cell Lung Cancer Therapeutics Market Share (2019-2020)
Table 64. India Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Small Cell Lung Cancer Therapeutics Market Share by Type (2015-2020)
Table 66. India Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Small Cell Lung Cancer Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Small Cell Lung Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Small Cell Lung Cancer Therapeutics Market Share (2019-2020)
Table 70. Central & South America Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Small Cell Lung Cancer Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Small Cell Lung Cancer Therapeutics Market Share by Application (2015-2020)
Table 74. Sanofi Company Details
Table 75. Sanofi Business Overview
Table 76. Sanofi Product
Table 77. Sanofi Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 78. Sanofi Recent Development
Table 79. Bristol-Myers Squibb Company Details
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Product
Table 82. Bristol-Myers Squibb Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. GlaxoSmithKline Company Details
Table 85. GlaxoSmithKline Business Overview
Table 86. GlaxoSmithKline Product
Table 87. GlaxoSmithKline Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 88. GlaxoSmithKline Recent Development
Table 89. Menarini Company Details
Table 90. Menarini Business Overview
Table 91. Menarini Product
Table 92. Menarini Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 93. Menarini Recent Development
Table 94. Ziopharm Oncology Company Details
Table 95. Ziopharm Oncology Business Overview
Table 96. Ziopharm Oncology Product
Table 97. Ziopharm Oncology Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 98. Ziopharm Oncology Recent Development
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Product
Table 102. Merck Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 103. Merck Recent Development
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Product
Table 107. Novartis Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 108. Novartis Recent Development
Table 109. AstraZeneca Business Overview
Table 110. AstraZeneca Product
Table 111. AstraZeneca Company Details
Table 112. AstraZeneca Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 113. AstraZeneca Recent Development
Table 114. Takeda Pharmaceutical Company Details
Table 115. Takeda Pharmaceutical Business Overview
Table 116. Takeda Pharmaceutical Product
Table 117. Takeda Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 118. Takeda Pharmaceutical Recent Development
Table 119. Teva Pharmaceutical Company Details
Table 120. Teva Pharmaceutical Business Overview
Table 121. Teva Pharmaceutical Product
Table 122. Teva Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 123. Teva Pharmaceutical Recent Development
Table 124. Eli Lilly Company Details
Table 125. Eli Lilly Business Overview
Table 126. Eli Lilly Product
Table 127. Eli Lilly Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 128. Eli Lilly Recent Development
Table 129. Mylan Company Details
Table 130. Mylan Business Overview
Table 131. Mylan Product
Table 132. Mylan Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 133. Mylan Recent Development
Table 134. Sun Pharmaceuticals Industries Company Details
Table 135. Sun Pharmaceuticals Industries Business Overview
Table 136. Sun Pharmaceuticals Industries Product
Table 137. Sun Pharmaceuticals Industries Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 138. Sun Pharmaceuticals Industries Recent Development
Table 139. Amgen Company Details
Table 140. Amgen Business Overview
Table 141. Amgen Product
Table 142. Amgen Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 143. Amgen Recent Development
Table 144. Ono Pharmaceutical Company Details
Table 145. Ono Pharmaceutical Business Overview
Table 146. Ono Pharmaceutical Product
Table 147. Ono Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 148. Ono Pharmaceutical Recent Development
Table 149. Shanghai Jinhe Bio-Technology Company Details
Table 150. Shanghai Jinhe Bio-Technology Business Overview
Table 151. Shanghai Jinhe Bio-Technology Product
Table 152. Shanghai Jinhe Bio-Technology Revenue in Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$)
Table 153. Shanghai Jinhe Bio-Technology Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Cell Lung Cancer Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Biologics Features
Figure 3. Small molecules Features
Figure 4. Global Small Cell Lung Cancer Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Other Case Studies
Figure 8. Small Cell Lung Cancer Therapeutics Report Years Considered
Figure 9. Global Small Cell Lung Cancer Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Small Cell Lung Cancer Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Small Cell Lung Cancer Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Small Cell Lung Cancer Therapeutics Market Share by Players in 2019
Figure 14. Global Top Small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Cell Lung Cancer Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Small Cell Lung Cancer Therapeutics Revenue in 2019
Figure 16. North America Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
非小細胞肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Non-small Cell Lung Cancer Therapeutics Market The global Non-small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Non-small Cell Lung Cancer Therapeu…- 小細胞肺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Small Cell Lung Cancer Treatment Scope and Market…
- 肺がん診断・治療の世界市場（～2026年） Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the …
- 肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Therapeutics Market The global Lung Cancer Therapeutics market size is projected to reach US$ 15800 million by 2026, from US$ 14180 million in 2020, at a CAGR of 10.6%% during 2021-2026. Global Lung Cancer Therapeutics Scope and Market Size Lung Cance…
- スモールセルネットワークの世界市場（～2026年） Small cells are low-powered cellular radio access nodes that operate in licensed and unlicensed spectrum that have a range of 10 meters to a few kilometers. They are "small" compared to a mobile macrocell, partly because they have a shorter range and partly because they typically handle fewer concur…